Dr. Qing Tang's lab at the University of Nebraska Lincoln is focused on understanding how the Arp2/3 complex, a key player in actin assembly, regulates cellular processes. Through advanced imaging techniques, the lab studies how this complex interacts with various partners in living cells, which is important for understanding muscle contraction, immune responses, and cancer metastasis. The research aims to uncover how disruptions in these processes contribute to diseases, advancing both basic science and potential therapies.

Walter J Atwood's lab at Brown University focuses on understanding Progressive Multifocal Leukoencephalopathy (PML), a severe brain disease caused by the JC virus, especially in patients with weak immune systems like those with AIDS or undergoing certain therapies. The lab investigates how the virus persists in the body and spreads to the brain, aiming to identify early biomarkers for PML and develop new treatment strategies. The research is important for improving outcomes for vulnerable populations affected by this fatal disease.

Dr. Daniel J. Klionsky's lab at the University of Michigan focuses on understanding autophagy, a crucial cellular process for maintaining health and preventing disease. They explore how this process is regulated and its implications for conditions like cancer, heart disease, and neurodegeneration. By studying yeast models, the lab aims to uncover the molecular mechanisms and proteins involved in autophagy, providing insights that could lead to new therapeutic strategies.

Dr. Keriann Marie Backus leads a research lab at UCLA focused on developing advanced techniques to discover new cancer drug targets. Her work emphasizes the use of chemoproteomics, a method that utilizes mass spectrometry to identify proteins that can be targeted by cysteine-reactive drugs. By improving screening methods and enhancing the detection of functionally relevant cysteines, her lab aims to facilitate the discovery of powerful new therapeutics for precision cancer treatment.

Dr. Michael P Terns' lab focuses on understanding how bacteria defend themselves against viruses using CRISPR-Cas systems and how viruses counter these defenses. They study the molecular mechanisms behind these interactions to enhance CRISPR technologies for medical applications. The ultimate goal is to apply this knowledge to improve tools for gene editing, disease diagnosis, and combating antibiotic resistance.

Dr. Lu Bai's lab at Penn State University focuses on understanding how chromatin structure influences gene regulation. The lab investigates the mechanisms that lead to chromatin accessibility and the organization of chromosomes within the nucleus. This research is significant for unraveling the complexities of gene expression, particularly in relation to human diseases.

Dr. Ruma V Banerjee's lab at the University of Michigan focuses on the intricate process of Vitamin B12 trafficking in the cell. They study how this essential nutrient is guided by specific proteins, called chaperones, to reach its target enzymes in the cytoplasm and mitochondria. The lab is particularly interested in understanding the molecular mechanisms that underlie inherited defects in Vitamin B12 metabolism, which can lead to serious health issues.

Dr. Gregory Barton's research lab at UC Berkeley is focused on understanding how the immune system differentiates between self and non-self nucleic acids to prevent autoimmune diseases. His team studies Toll-like receptors (TLRs), especially TLR7 and TLR9, which are critical in regulating immune responses. They are exploring how specific proteins and external signals affect these receptors' functions, with the goal of developing better therapies for autoimmune conditions and enhancing tissue repair processes.

Dr. Kara A. Bernstein's lab at the University of Pennsylvania focuses on understanding how a particular protein complex, called the Shu complex, helps repair DNA damage caused by environmental factors. They study both yeast and human cells to learn about the mechanisms of DNA repair and how disruptions in these processes can lead to cancer. By exploring these fundamental processes, the lab aims to uncover new insights that could help identify individuals at greater risk for cancer due to mutations in the genes involved.

Dr. Feyza Engin's lab focuses on understanding how stress affects insulin-producing beta cells in Type 1 diabetes (T1D). They explore the different responses beta cells exhibit under stress, which can either lead to disease progression or help protect against it. By studying these responses, the lab aims to uncover potential therapeutic targets for preserving healthy insulin production in diabetic patients.

Dr. Aparna Bhaduri's research lab at UCLA focuses on understanding how the human brain develops, particularly the processes that determine the specific types of cells formed in different brain areas. By studying how these processes go awry in conditions like neurodevelopmental disorders, the lab aims to improve models for brain development and potentially find new approaches to treat these disorders.

Dr. Michael D. Sheets' lab at the University of Wisconsin-Madison studies how specific proteins control gene expression during development, focusing on a protein called Bicaudal-C. This protein is crucial for making cell fate decisions that guide the normal development of vertebrates, including humans. The lab employs innovative techniques to unravel Bicaudal-C's role in regulating mRNA translation, which may lead to better understanding of diseases linked to cell dysfunction.

Dr. Bidadi Venkataram Prasad's lab at Baylor College of Medicine focuses on understanding the structure and function of rotaviruses, which are a leading cause of severe diarrhea in young children. The lab employs advanced imaging techniques, including cryo-electron microscopy, to investigate how viral proteins contribute to the virus's ability to replicate and form infectious particles. Their research aims to provide critical insights that can lead to new antiviral strategies against rotavirus infection and improve vaccine effectiveness.

Dr. Gopal Thinakaran's lab focuses on understanding the role of a protein called BIN1 in Alzheimer's disease. They study how BIN1 influences inflammation and the progression of neurodegenerative processes related to amyloid and tau proteins in the brain. The research involves using specific mouse models to investigate the mechanisms through which BIN1 impacts brain health and disease, with the ultimate goal of uncovering potential therapeutic targets for Alzheimer's.

Dr. Sapna K Deo's lab focuses on developing rapid diagnostic tests for urinary tract infections (UTIs) and antibiotic resistance. By leveraging bioluminescence technology, the lab aims to create innovative testing methods that can quickly and accurately determine the bacterial load in urine and identify antibiotic-resistant bacteria. This research addresses critical healthcare challenges related to bacterial infections and antibiotic misuse.

Dr. Vinata B Lokeshwar's lab at Augusta University focuses on improving treatments for high-risk bladder cancer. Their research investigates how to overcome resistance to chemotherapy, specifically the drug Gemcitabine, by targeting a newly identified enzyme called Chase. The lab aims to develop combination therapies that enhance the effectiveness of existing treatments and to identify biomarkers that help predict patient responses to these therapies.

The research lab, led by Dr. Onn Brandman at Stanford University, investigates how cells respond to stress and maintain the stability of proteins, essential for healthy cell function. By studying the mechanisms of protein production and quality control, the lab seeks to uncover insights into how these processes go awry in diseases and during aging. Their work aims to advance our understanding of cellular survival strategies and the fundamental biology behind diseases.

Dr. Gloria Ann Brar's lab focuses on understanding how cells rejuvenate their protein components during the formation of gametes, which are essential for sexual reproduction. By studying the simple budding yeast, they aim to identify the key proteins that are reset to maintain their youthfulness, even when derived from older cells. This research could provide insights into aging and new strategies to combat age-related cellular damage.

Dr. Jailson Brito Querido's lab at the University of Michigan studies the role of a specific genetic mutation in two serious neurodegenerative diseases: Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Their work focuses on understanding how abnormal translation of RNA—specifically a repeat in the C9orf72 gene—leads to the formation of toxic proteins that damage neurons. By using advanced imaging and molecular techniques, they aim to uncover details of how this process happens and how it could be targeted for future therapies.

The Brown lab at Harvard Medical School focuses on understanding how tiny structures called cilia and flagella function in various organisms, including humans and parasites. Their research explores the molecular mechanisms that control the movement of these structures, which play crucial roles in processes like fertility and disease. By using cutting-edge techniques, they hope to uncover how these movements are regulated and how this knowledge can lead to new treatments for diseases caused by parasites that affect millions of people.